Hemrage Sofia, Parkin Stephen, Kalk Nicola, Shah Naina, Deluca Paolo, Drummond Colin
Department of Addictions, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Department of Public Health, Environments and Society at London School of Hygiene and Tropical Medicine, London, UK.
Alcohol Clin Exp Res (Hoboken). 2024 Oct;48(10):1965-1978. doi: 10.1111/acer.15427. Epub 2024 Aug 27.
Effective interventions to improve patient outcomes in comorbid alcohol use disorder (AUD) and alcohol-related liver disease (ARLD) remain a clinical unmet need. While the choice of abstinence is the cornerstone for the prevention of disease progression and mortality, evidence suggests a suboptimal engagement with treatment supporting recovery. This qualitative investigation aims to understand barriers and facilitators to treatment as experienced by this clinical population by applying a multidimensional adherence model proposed by the World Health Organization.
Twenty-four participants with comorbid AUD and ARLD were recruited from an inpatient clinical setting. Data for this study were collected through semistructured, in-depth interviews. Deductive analysis was organized by the Framework method, and theory-driven themes were identified according to the multidimensional adherence model. This included factors across the social and economic, patient, condition, treatment, and healthcare system levels.
The findings in this study indicate systematic challenges in maintaining continuity between primary, secondary, and community care. Aspects related to social and economic context, treatment, and healthcare systems were found to hinder engagement. Identified facilitators to engagement included the participatory role of family, shared lived experience of addiction/recovery, and therapeutic alliance with healthcare providers.
The understanding of these barriers and facilitators from a service user's perspective can bridge the treatment gap for this clinical population. This can provide an opportunity for the implementation of effective interventions and inform the development of policies promoting accessible care. Government and public health bodies have fundamental roles in shifting treatment paradigms in comorbid AUD and ARLD.
改善合并酒精使用障碍(AUD)和酒精相关肝病(ARLD)患者预后的有效干预措施仍是临床未满足的需求。虽然戒酒的选择是预防疾病进展和死亡的基石,但证据表明,支持康复的治疗参与度欠佳。本定性研究旨在通过应用世界卫生组织提出的多维依从性模型,了解这一临床人群在治疗中所经历的障碍和促进因素。
从住院临床环境中招募了24名合并AUD和ARLD的参与者。本研究的数据通过半结构化深度访谈收集。采用框架法进行演绎分析,并根据多维依从性模型确定理论驱动的主题。这包括社会经济、患者、病情、治疗和医疗保健系统层面的因素。
本研究结果表明,在初级、二级和社区护理之间保持连续性方面存在系统性挑战。发现与社会经济背景、治疗和医疗保健系统相关的方面会阻碍参与。确定的参与促进因素包括家庭的参与作用、成瘾/康复的共同生活经历以及与医疗保健提供者的治疗联盟。
从服务使用者的角度理解这些障碍和促进因素,可以弥合这一临床人群的治疗差距。这可以为实施有效干预措施提供机会,并为促进可及护理的政策制定提供信息。政府和公共卫生机构在改变合并AUD和ARLD的治疗模式方面具有重要作用。